Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.44 USD
Change Today -0.05 / -1.43%
Volume 1.9M
EXEL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stelios Papadopoulos Ph.D.

Chairman of the Board and Member of Audit Committee, Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 89 board members in 9 different organizations across 13 different industries.

See Board Relationships
67$172,845

Background*

Dr. Stelios Papadopoulos, Ph.D., is a Co-Founder of Exelixis, Inc. and has been its Chairman of the Board since January 1998. Dr. Papadopoulos is a Co-Founder of Fondation Santé and serves as its Chairman. He co-founded Cellzome Inc. in 2000 and has been its Chairman since its inception. He co-founded Cellzome AG in 2000. He is a private biotechnology investor. His career in biopharmaceuticals spans more than two decades. He served as Managing Director of Life Sciences ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

Former Vice Chairman
Co-Founder and Director
Former Vice Chairman and Managing Director
Director
1991-N/A
Former Director
1994-Present
Chairman of the Board and Member of Audit Committee
2000-2011
Former Co-Founder, Chairman, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee
2001-2006
Former Director
2003-2006
Former Director
2003-Present
Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
2008-Present
Chairman, Member of Science & Technology Committee, Member of Audit Committee and Member of Finance Committee
2009-Present
Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee

Education*

PhD
New York University
MBA
New York University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$58,250
Total Calculated Compensation$172,845
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $3.44 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
$548.8K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$464.2K
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$551.7K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.